SCHEMBL2967385

SCHEMBL2967385

Cc1nn(S(=O)(=O)c2cc(Cl)cc(Cl)c2)c2ccc(NC(C(=O)O)S(=O)(=O)c3cc(Cl)cc(Cl)c3)cc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.42
CYP2D6 P10635 2/20 0.42
ACLY P53396 5/20 0.36
MAPT P10636 1/20 0.35
POLB P06746 1/20 0.34
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
KMO O15229 1/20 0.32
CNR1 P21554 1/20 0.32
PLK1 P53350 1/20 0.32
IDO1 P14902 1/20 0.31
PSEN1 P49768 2/20 0.30
PSEN2 P49810 2/20 0.30
APH1B Q8WW43 2/20 0.30
NCSTN Q92542 2/20 0.30
APH1A Q96BI3 2/20 0.30
PSENEN Q9NZ42 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2846115 0.79 PSEN1 (0.46) CYP3A4CYP2D6ACLYMAPTPSEN1
SCHEMBL2967390 0.75 CYP3A4 (0.37) CYP3A4CYP2D6ACLYMAPTALDH1A1
SCHEMBL10317472 0.71 ACLY (0.35) ACLYPSEN1PSEN2APH1BNCSTN
SCHEMBL4570713 0.62 ADRB2 (0.34) MEN1KMT2AIDO1
SCHEMBL17927652 0.62 KMT2A (0.41) MAPTPOLBALDH1A1LMNANPSR1
SCHEMBL1272497 0.61 MAPT (0.50) MAPTPOLBALDH1A1LMNAMEN1
SCHEMBL29136975 0.58 LMNA (0.43) CYP3A4CYP2D6MAPTALDH1A1LMNA
SCHEMBL12253486 0.57 SLC9A1 (0.56) MAPTPOLBALDH1A1LMNAMEN1
SCHEMBL3960290 0.57 KMT2A (0.42) MAPTPOLBALDH1A1LMNANPSR1
SCHEMBL13797492 0.56 POLB (0.39) ACLYMAPTPOLBALDH1A1CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2125718-B1 NEW SUBSTITUTED ARYLSULPHONYLGLYCINES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS BOEHRINGER INGELHEIM INT (DE) 2010-09-15 EP disclosed